STOCK TITAN
  1. Home
  2. Sec-filings
  3. HNGE
  4. [Form 4] Hinge Health, Inc. Insider Trading Activity

Bessemer funds tied to Hinge Health (NASDAQ: HNGE) report June share sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hinge Health, Inc. reported June transactions in which Bessemer Venture Partners funds sold Class A Common Stock. On June 10, 2026, Bessemer Venture Partners X L.P. sold 15,619 shares and Bessemer Venture Partners X Institutional L.P. sold 14,662 shares at a weighted average price of $65.20, in multiple trades between $65.00 and $65.88. On June 11, 2026, the same funds sold 30,042 and 28,201 shares, respectively, at a weighted average price of $66.02, with prices from $65.55 to $66.45. On June 12, 2026, they sold 8,694 and 8,161 shares, respectively, at a weighted average price of $65.24, in trades between $65.00 and $66.00. Director Robinson Elliott is a partner at Bessemer Venture Partners and reports an indirect, passive economic interest in these holdings and expressly disclaims beneficial ownership except to the extent of any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Robinson Elliott
Role null
Sold 0 shs ($0.00)
Type Security Shares Price Value
Sale Class A Common Stock 0 $0.00 --
Sale Class A Common Stock 0 $0.00 --
Sale Class A Common Stock 0 $0.00 --
Holdings After Transaction: Class A Common Stock — 0 shares (Indirect, See footnote)
Footnotes (1)
  1. On June 10, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 15,619 and 14,662 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.20. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. On June 11, 2026, BVP X and BVP X Inst sold 30,042 and 28,201 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $66.02. These shares were sold in multiple transactions at prices ranging from $65.55 to $66.45. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. On June 12, 2026, BVP X and BVP X Inst sold 8,694 and 8,161 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.24. These shares were sold in multiple transactions at prices ranging from $65.00 to $66.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
June 10 BVP X sale 15,619 shares Class A Common Stock sold at $65.20 weighted average
June 10 BVP X Inst sale 14,662 shares Class A Common Stock sold at $65.20 weighted average
June 11 BVP X sale 30,042 shares Sold at $66.02 weighted average (range $65.55–$66.45)
June 11 BVP X Inst sale 28,201 shares Sold at $66.02 weighted average (range $65.55–$66.45)
June 12 BVP X sale 8,694 shares Sold at $65.24 weighted average (range $65.00–$66.00)
June 12 BVP X Inst sale 8,161 shares Sold at $65.24 weighted average (range $65.00–$66.00)
June 10 price range $65.00–$65.88 Price range for June 10, 2026 sales
June 11 price range $65.55–$66.45 Price range for June 11, 2026 sales
Class A Common Stock financial
"shares of Class A Common Stock of the Issuer, respectively, at a weighted"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
weighted average price financial
"sold 15,619 and 14,662 shares ... at a weighted average price of $65.20"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the securities held"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest, if any, in such securities"
indirect, passive economic interest financial
"has an indirect, passive economic interest in the shares held by the"
Bessemer Venture Partners X Institutional L.P. financial
"Bessemer Venture Partners X Institutional L.P. ("BVP X Inst")"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Robinson Elliott
(Last)(First)(Middle)
C/O BESSEMER VENTURE PARTNERS
1865 PALMER AVENUE, SUITE 104
(Street)
LARCHMONT NEW YORK 10538
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/10/2026S0(1)D$00ISee footnote(1)(3)
Class A Common Stock06/11/2026S0(1)D$00ISee footnote(2)(3)
Class A Common Stock06/12/2026S0(1)D$00ISee footnote(3)(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. On June 10, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 15,619 and 14,662 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.20. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. On June 11, 2026, BVP X and BVP X Inst sold 30,042 and 28,201 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $66.02. These shares were sold in multiple transactions at prices ranging from $65.55 to $66.45. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
4. On June 12, 2026, BVP X and BVP X Inst sold 8,694 and 8,161 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.24. These shares were sold in multiple transactions at prices ranging from $65.00 to $66.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Augie Wilkinson, Attorney-in-Fact06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Hinge Health (HNGE) disclose in this Form 4?

Hinge Health disclosed that Bessemer Venture Partners funds sold Class A Common Stock over three days in June 2026. The trades involved multiple block transactions at weighted average prices around the mid-$60 range, as detailed in the filing footnotes.

Who actually sold Hinge Health (HNGE) shares in the reported transactions?

The sales were made by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. Director Robinson Elliott is a partner at Bessemer and reports only an indirect, passive economic interest in these funds’ Hinge Health shares.

How many Hinge Health (HNGE) shares did Bessemer funds sell on June 10, 2026?

On June 10, 2026, Bessemer Venture Partners X L.P. sold 15,619 Hinge Health Class A shares, and Bessemer Venture Partners X Institutional L.P. sold 14,662 shares at a weighted average price of $65.20, across multiple trades within a disclosed price range.

What was reported for the June 12, 2026 Hinge Health (HNGE) share sales?

On June 12, 2026, Bessemer Venture Partners X L.P. sold 8,694 shares and Bessemer Venture Partners X Institutional L.P. sold 8,161 shares at a weighted average price of $65.24, with multiple transactions completed between $65.00 and $66.00 per share.

Does Hinge Health director Robinson Elliott claim full ownership of the sold shares?

No. Robinson Elliott states he has an indirect, passive economic interest through Bessemer entities and disclaims beneficial ownership of the Bessemer funds’ Hinge Health securities, except to the extent of any pecuniary interest attributable to his indirect fund interests.